価格表

在庫・価格 : 2025年04月27日 05時53分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-SOST, Mouse, Goat-Poly
データシート※最新のデータシートでない場合があります
AF1589 RSDアールアンドディー システムズ
R&D Systems, Inc.
100 μg ¥106,000
(未発注)
追加

在庫・価格 : 2025年04月27日 05時53分 現在

Anti-SOST, Mouse, Goat-Poly

  • 商品コード:AF1589
  • メーカー:RSD
  • 包装:100μg
  • 価格: ¥106,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Leupin O et al. Control of the SOST bone enhancer by PTH using MEF2 transcription factors. J. Bone Miner. Res. 2007 Dec;22(12):1957-67
Leupin O et al
2007/01/01
Species: Rat, Application: IHC Fresh/Frozen, Sample type: Whole Cells PubMed
2 Wan M et al. Parathyroid hormone signaling through low-density lipoprotein-related protein 6. Genes Dev. 2008 Nov;22(21):2968-79
Wan M et al
2008/01/01
Application: IHC Fresh, Sample Type: Whole Tissue PubMed
3 Lin C et al. Sclerostin mediates bone response to mechanical unloading through antagonizing Wnt/beta-catenin signaling. J. Bone Miner. Res. 2009 Oct;24(10):1651-61
Lin C et al
2009/01/01
Application: Western Blot, Sample Type: Homogenized Tissue PubMed
4 J辰ger A et al. Localization of SOST/sclerostin in cementocytes in vivo and in mineralizing periodontal ligament cells in vitro. J. Periodont. Res. 2010 Apr;45(2):246-54
J辰ger A et al
2010/01/01
Application: IHC Paraffin-embedded, Sample Type: Whole Tissue PubMed
5 Genetos DC et al. Hypoxia decreases sclerostin expression and increases Wnt signaling in osteoblasts. J. Cell. Biochem. 2010 May;110(2):457-67
Genetos DC et al
2010/01/01
Application: Western Blot, Sample Type: Cell Lysates PubMed
6 Krause C et al. Distinct modes of inhibition by sclerostin on bone morphogenetic protein and Wnt signaling pathways. J. Biol. Chem. 2010 Dec;285(53):41614-26
Krause C et al
2010/01/01
Application: IHC Paraffin, Sample Type: Whole Tissue PubMed
7 Zhu D et al. The appearance and modulation of osteocyte marker expression during calcification of vascular smooth muscle cells. PLoS ONE 2011;6(5):e19595
Zhu D et al
2011/01/01
Application: IHC Paraffin-embedded,Western Blot, Sample Type: Cell Lysates,Whole Tissue PubMed
8 Rhee Y et al. Parathyroid hormone receptor signaling in osteocytes increases the expression of fibroblast growth factor-23 in vitro and in vivo. Bone 2011 Oct;49(4):636-43
Rhee Y et al
2011/01/01
Application: IHC Paraffin-embedded, Sample Type: Whole Tissue PubMed
9 Okamoto M et al. Conditional deletion of Bmpr1a in differentiated osteoclasts increases osteoblastic bone formation, increasing volume of remodeling bone in mice. J. Bone Miner. Res. 2011 Oct;26(10):2511-22
Okamoto M et al
2011/01/01
Application: IHC Paraffin-embedded, Sample Type: Whole Tissue PubMed
10 Sabbagh Y et al. Repression of osteocyte Wnt/β-catenin signaling is an early event in the progression of renal osteodystrophy. J. Bone Miner. Res. 2012 Aug;27(8):1757-72
Sabbagh Y et al
2012/01/01
Application: IHC Paraffin-embedded, Sample Type: Whole Tissue PubMed
11 Hassan MQ et al. miR-218 directs a Wnt signaling circuit to promote differentiation of osteoblasts and osteomimicry of metastatic cancer cells. J. Biol. Chem. 2012 Dec;287(50):42084-92
Hassan MQ et al
2012/01/01
Application: Western Blot, Sample Type: Cell Lysates PubMed
12 Tang SY et al. Matrix metalloproteinase-13 is required for osteocytic perilacunar remodeling and maintains bone fracture resistance. J. Bone Miner. Res. 2012 Sep;27(9):1936-50
Tang SY et al
2012/01/01
Application: IHC Frozen, Sample Type: Whole Tissue PubMed
13 Loiselle AE et al. Inhibition of GSK-3β rescues the impairments in bone formation and mechanical properties associated with fracture healing in osteoblast selective connexin 43 deficient mice. PLoS ONE 2013;8(11):e81399
Loiselle AE et al
2013/01/01
Application: IHC Paraffin-embedded, Sample Type: Whole Tissue PubMed
14 Akil O et al. Disrupted bone remodeling leads to cochlear overgrowth and hearing loss in a mouse model of fibrous dysplasia. PLoS ONE 2014;9(5):e94989
Akil O et al
2014/01/01
Application: IHC, Sample Type: tissue PubMed
15 St John HC et al. The osteoblast to osteocyte transition: epigenetic changes and response to the vitamin D3 hormone. Mol. Endocrinol. 2014 Jul;28(7):1150-65
St John HC et al
2014/01/01
Application: Western Blot, Sample Type: Cell Lysates PubMed
16 Tu X et al. Osteocytes mediate the anabolic actions of canonical Wnt/β-catenin signaling in bone. Proc. Natl. Acad. Sci. U.S.A. 2015 Feb;112(5):E478-86
Tu X et al
2015/01/01
Application: IHC Paraffin-embedded, Sample Type: Whole Tissue PubMed
17 Sinnesael M et al. Androgens inhibit the osteogenic response to mechanical loading in adult male mice. Endocrinology 2015 Apr;156(4):1343-53
Sinnesael M et al
2015/01/01
Application: IHC, Sample Type: Whole Tissue PubMed
18 Prideaux M et al. Parathyroid Hormone Induces Bone Cell Motility and Loss of Mature Osteocyte Phenotype through L-Calcium Channel Dependent and Independent Mechanisms. PLoS ONE 2015;10(5):e0125731
Prideaux M et al
2015/01/01
Application: Western Blot, Sample Type: Cell Lysates PubMed
19 Spatz JM et al. The Wnt Inhibitor Sclerostin Is Up-regulated by Mechanical Unloading in Osteocytes in Vitro. J. Biol. Chem. 2015 Jul;290(27):16744-58
Spatz JM et al
2015/01/01
Application: Western Blot, Sample Type: Cell Lysate PubMed
20 Beier EE et al. Heavy Metal Ion Regulation of Gene Expression: MECHANISMS BY WHICH LEAD INHIBITS OSTEOBLASTIC BONE-FORMING ACTIVITY THROUGH MODULATION OF THE Wnt/β-CATENIN SIGNALING PATHWAY. J. Biol. Chem. 2015 Jul;290(29):18216-26
Beier EE et al
2015/01/01
Application: Western Blot, Sample Type: Cell Lysates PubMed
21 Amri N et al. Distorted Patterns of Dentinogenesis and Eruption in Msx2 Null Mutants: Involvement of Sost/Sclerostin. Am. J. Pathol. 2016 Oct;186(10):2577-87
Amri N et al
2016/01/01
Application: IHC - Paraffin embedded, Sample Type: Whole Tissue PubMed
22 Chandra A et al. Suppression of Sclerostin Alleviates Radiation-Induced Bone Loss by Protecting Bone-Forming Cells and Their Progenitors Through Distinct Mechanisms. J. Bone Miner. Res. 2016 Sep;
Chandra A et al
2016/01/01
Application: IHC Frozen, Sample Type: Whole Tissue PubMed
23 Shu R et al. Sclerostin Promotes Bone Remodeling in the Process of Tooth Movement. PLoS ONE 2017;12(1):e0167312
Shu R et al
2017/01/01
Application: IHC, Sample Type: Whole Tissue PubMed
24 Ogura K et al. Short-term intermittent administration of parathyroid hormone facilitates osteogenesis by different mechanisms in cancellous and cortical bone. Bone Rep 2016 Dec;5:7-14
Ogura K et al
2016/01/01
Application: IHC, Sample Type: Whole Tissue PubMed
25 Ramaswamy G et al. Gsα Controls Cortical Bone Quality by Regulating Osteoclast Differentiation via cAMP/PKA and β-Catenin Pathways. Sci Rep 2017 Mar;7:45140
Ramaswamy G et al
2017/01/01
Application: IHC, Sample Type: Whole Tissue PubMed
26 Cui P et al. Zoledronate promotes bone formation by blocking osteocyte-osteoblast communication during bone defect healing. Histol. Histopathol. 2017 Mar;:11893
Cui P et al
2017/01/01
Application: IHC Paraffin-embedded, Sample Type: Whole Tissue PubMed
27 Sakurai A et al. Chronological immunolocalization of sclerostin and FGF23 in the mouse metaphyseal trabecular and cortical bone. Biomed. Res. 2017;38(4):257-267
Sakurai A et al
2017/01/01
Application: IHC paraffin embedded, Sample Type: Whole Tissue PubMed
28 Saito H et al. TG-interacting factor 1 (Tgif1)-deficiency attenuates bone remodeling and blunts the anabolic response to parathyroid hormone. Nat Commun 2019 03;10(1):1354
Saito H et al
2019/01/01
PubMed
29 Supakul S et al. Pericytes as a Source of Osteogenic Cells in Bone Fracture Healing. Int J Mol Sci 2019 Mar;20(5)
Supakul S et al
2019/01/01
PubMed
30 Yamaguchi Y et al. Sclerostin is upregulated in the early stage of chondrogenic differentiation, but not required in endochondral ossification in vitro. PLoS ONE 2018;13(8):e0201839
Yamaguchi Y et al
2018/01/01
PubMed
31 Javaheri B et al. Transient peak-strain matching partially recovers the age-impaired mechanoadaptive cortical bone response. Sci Rep 2018 Apr;8(1):6636
Javaheri B et al
2018/01/01
PubMed
32 Kamimoto H et al. Relaxin 2 carried by magnetically directed liposomes accelerates rat midpalatal suture expansion and subsequent new bone formation. Bone Rep 2019 Jun;10:100202
Kamimoto H et al
2019/01/01
PubMed
33 Kim AR et al. Simvastatin attenuates tibial bone loss in rats with type 1 diabetes and periodontitis. J Transl Med 2018 11;16(1):306
Kim AR et al
2018/01/01
PubMed
34 Inoue M et al. Forceful mastication activates osteocytes and builds a stout jawbone. Sci Rep 2019 Mar;9(1):4404
Inoue M et al
2019/01/01
PubMed
35 Xiao L et al. FGF2 crosstalk with Wnt signaling in mediating the anabolic action of PTH on bone formation. Bone Rep 2018 Dec;9:136-144
Xiao L et al
2018/01/01
PubMed
36 Metzger CE et al. Inflammatory Bowel Disease in a Rodent Model Alters Osteocyte Protein Levels Controlling Bone Turnover. J. Bone Miner. Res. 2017 04;32(4):802-813
Metzger CE et al
2017/01/01
PubMed
37 Gardinier JD et al. Bone adaptation in response to treadmill exercise in young and adult mice. Bone Rep 2018 Jun;8:29-37
Gardinier JD et al
2018/01/01
PubMed
38 Svandova E et al. FasL Modulates Expression of <i>Mmp2</i> in Osteoblasts. Front Physiol 2018;9:1314
Svandova E et al
2018/01/01
PubMed
39 Lotinun S et al. Cathepsin K-deficient osteocytes prevent lactation-induced bone loss and parathyroid hormone suppression. J Clin Invest 2019 05;129(8):3058-3071
Lotinun S et al
2019/01/01
PubMed
40 Staines KA et al. Conditional deletion of E11/podoplanin in bone protects against load-induced osteoarthritis. BMC Musculoskelet Disord 2019 Jul;20(1):344
Staines KA et al
2019/01/01
PubMed
41 Morrell AE et al. Mechanically induced Ca<sup>2+</sup> oscillations in osteocytes release extracellular vesicles and enhance bone formation. Bone Res 2018;6:6
Morrell AE et al
2018/01/01
PubMed
42 Metzger CE et al. DSS-induced colitis produces inflammation-induced bone loss while irisin treatment mitigates the inflammatory state in both gut and bone. Sci Rep 2019 10;9(1):15144
Metzger CE et al
2019/01/01
PubMed
43 Narayanan SA et al. Inflammation-induced lymphatic architecture and bone turnover changes are ameliorated by irisin treatment in chronic inflammatory bowel disease. FASEB J. 2018 Sep;32(9):4848-4861
Narayanan SA et al
2018/01/01
PubMed
44 Ohori F et al. Effect of TNF-<i>&#x3B1;</i>-Induced Sclerostin on Osteocytes during Orthodontic Tooth Movement. J Immunol Res 2019;2019:9716758
Ohori F et al
2019/01/01
PubMed
45 Wehrle E et al. Evaluation of longitudinal time-lapsed in vivo micro-CT for monitoring fracture healing in mouse femur defect models. Sci Rep 2019 11;9(1):17445
Wehrle E et al
2019/01/01
PubMed
46 Pineault KM et al. Hox11 expressing regional skeletal stem cells are progenitors for osteoblasts, chondrocytes and adipocytes throughout life. Nat Commun 2019 07;10(1):3168
Pineault KM et al
2019/01/01
PubMed
47 Li J et al. SOST Deficiency Aggravates Osteoarthritis in Mice by Promoting Sclerosis of Subchondral Bone. Biomed Res Int 2019;2019:7623562
Li J et al
2019/01/01
PubMed
48 Nakatani T et al. The Deletion of Hdac4 in Mouse Osteoblasts Influences Both Catabolic and Anabolic Effects in Bone. J Bone Miner Res 2018 07;33(7):1362-1375
Nakatani T et al
2018/01/01
PubMed
49 Pacicca DM et al. Elevated glucose acts directly on osteocytes to increase sclerostin expression in diabetes. Sci Rep 2019 11;9(1):17353
Pacicca DM et al
2019/01/01
PubMed
50 Nguyen-Yamamoto L et al. Vitamin D-regulated osteocytic sclerostin and BMP2 modulate uremic extraskeletal calcification. JCI Insight 2019 07;4(13)
Nguyen-Yamamoto L et al
2019/01/01
PubMed
51 Koide M et al. Sclerostin expression in trabecular bone is downregulated by osteoclasts. Sci Rep 2020 08;10(1):13751
Koide M et al
2020/01/01
Species: Mouse, Applications: IHC PubMed
52 Song JY et al. <i>Hox</i> genes maintain critical roles in the adult skeleton. Proc Natl Acad Sci U S A 2020 03;117(13):7296-7304
Song JY et al
2020/01/01
Species: Mouse, Applications: IHC PubMed
  • No.: 1
  • 文献情報:
    Leupin O et al. Control of the SOST bone enhancer by PTH using MEF2 transcription factors. J. Bone Miner. Res. 2007 Dec;22(12):1957-67
    Leupin O et al
    2007/01/01
  • 備考:
    Species: Rat, Application: IHC Fresh/Frozen, Sample type: Whole Cells
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Wan M et al. Parathyroid hormone signaling through low-density lipoprotein-related protein 6. Genes Dev. 2008 Nov;22(21):2968-79
    Wan M et al
    2008/01/01
  • 備考:
    Application: IHC Fresh, Sample Type: Whole Tissue
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Lin C et al. Sclerostin mediates bone response to mechanical unloading through antagonizing Wnt/beta-catenin signaling. J. Bone Miner. Res. 2009 Oct;24(10):1651-61
    Lin C et al
    2009/01/01
  • 備考:
    Application: Western Blot, Sample Type: Homogenized Tissue
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    J辰ger A et al. Localization of SOST/sclerostin in cementocytes in vivo and in mineralizing periodontal ligament cells in vitro. J. Periodont. Res. 2010 Apr;45(2):246-54
    J辰ger A et al
    2010/01/01
  • 備考:
    Application: IHC Paraffin-embedded, Sample Type: Whole Tissue
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Genetos DC et al. Hypoxia decreases sclerostin expression and increases Wnt signaling in osteoblasts. J. Cell. Biochem. 2010 May;110(2):457-67
    Genetos DC et al
    2010/01/01
  • 備考:
    Application: Western Blot, Sample Type: Cell Lysates
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Krause C et al. Distinct modes of inhibition by sclerostin on bone morphogenetic protein and Wnt signaling pathways. J. Biol. Chem. 2010 Dec;285(53):41614-26
    Krause C et al
    2010/01/01
  • 備考:
    Application: IHC Paraffin, Sample Type: Whole Tissue
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Zhu D et al. The appearance and modulation of osteocyte marker expression during calcification of vascular smooth muscle cells. PLoS ONE 2011;6(5):e19595
    Zhu D et al
    2011/01/01
  • 備考:
    Application: IHC Paraffin-embedded,Western Blot, Sample Type: Cell Lysates,Whole Tissue
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Rhee Y et al. Parathyroid hormone receptor signaling in osteocytes increases the expression of fibroblast growth factor-23 in vitro and in vivo. Bone 2011 Oct;49(4):636-43
    Rhee Y et al
    2011/01/01
  • 備考:
    Application: IHC Paraffin-embedded, Sample Type: Whole Tissue
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Okamoto M et al. Conditional deletion of Bmpr1a in differentiated osteoclasts increases osteoblastic bone formation, increasing volume of remodeling bone in mice. J. Bone Miner. Res. 2011 Oct;26(10):2511-22
    Okamoto M et al
    2011/01/01
  • 備考:
    Application: IHC Paraffin-embedded, Sample Type: Whole Tissue
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Sabbagh Y et al. Repression of osteocyte Wnt/&#x3B2;-catenin signaling is an early event in the progression of renal osteodystrophy. J. Bone Miner. Res. 2012 Aug;27(8):1757-72
    Sabbagh Y et al
    2012/01/01
  • 備考:
    Application: IHC Paraffin-embedded, Sample Type: Whole Tissue
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Hassan MQ et al. miR-218 directs a Wnt signaling circuit to promote differentiation of osteoblasts and osteomimicry of metastatic cancer cells. J. Biol. Chem. 2012 Dec;287(50):42084-92
    Hassan MQ et al
    2012/01/01
  • 備考:
    Application: Western Blot, Sample Type: Cell Lysates
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Tang SY et al. Matrix metalloproteinase-13 is required for osteocytic perilacunar remodeling and maintains bone fracture resistance. J. Bone Miner. Res. 2012 Sep;27(9):1936-50
    Tang SY et al
    2012/01/01
  • 備考:
    Application: IHC Frozen, Sample Type: Whole Tissue
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Loiselle AE et al. Inhibition of GSK-3&#x3B2; rescues the impairments in bone formation and mechanical properties associated with fracture healing in osteoblast selective connexin 43 deficient mice. PLoS ONE 2013;8(11):e81399
    Loiselle AE et al
    2013/01/01
  • 備考:
    Application: IHC Paraffin-embedded, Sample Type: Whole Tissue
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Akil O et al. Disrupted bone remodeling leads to cochlear overgrowth and hearing loss in a mouse model of fibrous dysplasia. PLoS ONE 2014;9(5):e94989
    Akil O et al
    2014/01/01
  • 備考:
    Application: IHC, Sample Type: tissue
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    St John HC et al. The osteoblast to osteocyte transition: epigenetic changes and response to the vitamin D3 hormone. Mol. Endocrinol. 2014 Jul;28(7):1150-65
    St John HC et al
    2014/01/01
  • 備考:
    Application: Western Blot, Sample Type: Cell Lysates
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Tu X et al. Osteocytes mediate the anabolic actions of canonical Wnt/&#x3B2;-catenin signaling in bone. Proc. Natl. Acad. Sci. U.S.A. 2015 Feb;112(5):E478-86
    Tu X et al
    2015/01/01
  • 備考:
    Application: IHC Paraffin-embedded, Sample Type: Whole Tissue
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Sinnesael M et al. Androgens inhibit the osteogenic response to mechanical loading in adult male mice. Endocrinology 2015 Apr;156(4):1343-53
    Sinnesael M et al
    2015/01/01
  • 備考:
    Application: IHC, Sample Type: Whole Tissue
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Prideaux M et al. Parathyroid Hormone Induces Bone Cell Motility and Loss of Mature Osteocyte Phenotype through L-Calcium Channel Dependent and Independent Mechanisms. PLoS ONE 2015;10(5):e0125731
    Prideaux M et al
    2015/01/01
  • 備考:
    Application: Western Blot, Sample Type: Cell Lysates
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    Spatz JM et al. The Wnt Inhibitor Sclerostin Is Up-regulated by Mechanical Unloading in Osteocytes in Vitro. J. Biol. Chem. 2015 Jul;290(27):16744-58
    Spatz JM et al
    2015/01/01
  • 備考:
    Application: Western Blot, Sample Type: Cell Lysate
  • 参照:
    PubMed
  • No.: 20
  • 文献情報:
    Beier EE et al. Heavy Metal Ion Regulation of Gene Expression: MECHANISMS BY WHICH LEAD INHIBITS OSTEOBLASTIC BONE-FORMING ACTIVITY THROUGH MODULATION OF THE Wnt/&#x3B2;-CATENIN SIGNALING PATHWAY. J. Biol. Chem. 2015 Jul;290(29):18216-26
    Beier EE et al
    2015/01/01
  • 備考:
    Application: Western Blot, Sample Type: Cell Lysates
  • 参照:
    PubMed
  • No.: 21
  • 文献情報:
    Amri N et al. Distorted Patterns of Dentinogenesis and Eruption in Msx2 Null Mutants: Involvement of Sost/Sclerostin. Am. J. Pathol. 2016 Oct;186(10):2577-87
    Amri N et al
    2016/01/01
  • 備考:
    Application: IHC - Paraffin embedded, Sample Type: Whole Tissue
  • 参照:
    PubMed
  • No.: 22
  • 文献情報:
    Chandra A et al. Suppression of Sclerostin Alleviates Radiation-Induced Bone Loss by Protecting Bone-Forming Cells and Their Progenitors Through Distinct Mechanisms. J. Bone Miner. Res. 2016 Sep;
    Chandra A et al
    2016/01/01
  • 備考:
    Application: IHC Frozen, Sample Type: Whole Tissue
  • 参照:
    PubMed
  • No.: 23
  • 文献情報:
    Shu R et al. Sclerostin Promotes Bone Remodeling in the Process of Tooth Movement. PLoS ONE 2017;12(1):e0167312
    Shu R et al
    2017/01/01
  • 備考:
    Application: IHC, Sample Type: Whole Tissue
  • 参照:
    PubMed
  • No.: 24
  • 文献情報:
    Ogura K et al. Short-term intermittent administration of parathyroid hormone facilitates osteogenesis by different mechanisms in cancellous and cortical bone. Bone Rep 2016 Dec;5:7-14
    Ogura K et al
    2016/01/01
  • 備考:
    Application: IHC, Sample Type: Whole Tissue
  • 参照:
    PubMed
  • No.: 25
  • 文献情報:
    Ramaswamy G et al. Gs&#x3B1; Controls Cortical Bone Quality by Regulating Osteoclast Differentiation via cAMP/PKA and &#x3B2;-Catenin Pathways. Sci Rep 2017 Mar;7:45140
    Ramaswamy G et al
    2017/01/01
  • 備考:
    Application: IHC, Sample Type: Whole Tissue
  • 参照:
    PubMed
  • No.: 26
  • 文献情報:
    Cui P et al. Zoledronate promotes bone formation by blocking osteocyte-osteoblast communication during bone defect healing. Histol. Histopathol. 2017 Mar;:11893
    Cui P et al
    2017/01/01
  • 備考:
    Application: IHC Paraffin-embedded, Sample Type: Whole Tissue
  • 参照:
    PubMed
  • No.: 27
  • 文献情報:
    Sakurai A et al. Chronological immunolocalization of sclerostin and FGF23 in the mouse metaphyseal trabecular and cortical bone. Biomed. Res. 2017;38(4):257-267
    Sakurai A et al
    2017/01/01
  • 備考:
    Application: IHC paraffin embedded, Sample Type: Whole Tissue
  • 参照:
    PubMed
  • No.: 28
  • 文献情報:
    Saito H et al. TG-interacting factor 1 (Tgif1)-deficiency attenuates bone remodeling and blunts the anabolic response to parathyroid hormone. Nat Commun 2019 03;10(1):1354
    Saito H et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 29
  • 文献情報:
    Supakul S et al. Pericytes as a Source of Osteogenic Cells in Bone Fracture Healing. Int J Mol Sci 2019 Mar;20(5)
    Supakul S et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 30
  • 文献情報:
    Yamaguchi Y et al. Sclerostin is upregulated in the early stage of chondrogenic differentiation, but not required in endochondral ossification in vitro. PLoS ONE 2018;13(8):e0201839
    Yamaguchi Y et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 31
  • 文献情報:
    Javaheri B et al. Transient peak-strain matching partially recovers the age-impaired mechanoadaptive cortical bone response. Sci Rep 2018 Apr;8(1):6636
    Javaheri B et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 32
  • 文献情報:
    Kamimoto H et al. Relaxin 2 carried by magnetically directed liposomes accelerates rat midpalatal suture expansion and subsequent new bone formation. Bone Rep 2019 Jun;10:100202
    Kamimoto H et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 33
  • 文献情報:
    Kim AR et al. Simvastatin attenuates tibial bone loss in rats with type 1 diabetes and periodontitis. J Transl Med 2018 11;16(1):306
    Kim AR et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 34
  • 文献情報:
    Inoue M et al. Forceful mastication activates osteocytes and builds a stout jawbone. Sci Rep 2019 Mar;9(1):4404
    Inoue M et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 35
  • 文献情報:
    Xiao L et al. FGF2 crosstalk with Wnt signaling in mediating the anabolic action of PTH on bone formation. Bone Rep 2018 Dec;9:136-144
    Xiao L et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 36
  • 文献情報:
    Metzger CE et al. Inflammatory Bowel Disease in a Rodent Model Alters Osteocyte Protein Levels Controlling Bone Turnover. J. Bone Miner. Res. 2017 04;32(4):802-813
    Metzger CE et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 37
  • 文献情報:
    Gardinier JD et al. Bone adaptation in response to treadmill exercise in young and adult mice. Bone Rep 2018 Jun;8:29-37
    Gardinier JD et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 38
  • 文献情報:
    Svandova E et al. FasL Modulates Expression of <i>Mmp2</i> in Osteoblasts. Front Physiol 2018;9:1314
    Svandova E et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 39
  • 文献情報:
    Lotinun S et al. Cathepsin K-deficient osteocytes prevent lactation-induced bone loss and parathyroid hormone suppression. J Clin Invest 2019 05;129(8):3058-3071
    Lotinun S et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 40
  • 文献情報:
    Staines KA et al. Conditional deletion of E11/podoplanin in bone protects against load-induced osteoarthritis. BMC Musculoskelet Disord 2019 Jul;20(1):344
    Staines KA et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 41
  • 文献情報:
    Morrell AE et al. Mechanically induced Ca<sup>2+</sup> oscillations in osteocytes release extracellular vesicles and enhance bone formation. Bone Res 2018;6:6
    Morrell AE et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 42
  • 文献情報:
    Metzger CE et al. DSS-induced colitis produces inflammation-induced bone loss while irisin treatment mitigates the inflammatory state in both gut and bone. Sci Rep 2019 10;9(1):15144
    Metzger CE et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 43
  • 文献情報:
    Narayanan SA et al. Inflammation-induced lymphatic architecture and bone turnover changes are ameliorated by irisin treatment in chronic inflammatory bowel disease. FASEB J. 2018 Sep;32(9):4848-4861
    Narayanan SA et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 44
  • 文献情報:
    Ohori F et al. Effect of TNF-<i>&#x3B1;</i>-Induced Sclerostin on Osteocytes during Orthodontic Tooth Movement. J Immunol Res 2019;2019:9716758
    Ohori F et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 45
  • 文献情報:
    Wehrle E et al. Evaluation of longitudinal time-lapsed in vivo micro-CT for monitoring fracture healing in mouse femur defect models. Sci Rep 2019 11;9(1):17445
    Wehrle E et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 46
  • 文献情報:
    Pineault KM et al. Hox11 expressing regional skeletal stem cells are progenitors for osteoblasts, chondrocytes and adipocytes throughout life. Nat Commun 2019 07;10(1):3168
    Pineault KM et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 47
  • 文献情報:
    Li J et al. SOST Deficiency Aggravates Osteoarthritis in Mice by Promoting Sclerosis of Subchondral Bone. Biomed Res Int 2019;2019:7623562
    Li J et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 48
  • 文献情報:
    Nakatani T et al. The Deletion of Hdac4 in Mouse Osteoblasts Influences Both Catabolic and Anabolic Effects in Bone. J Bone Miner Res 2018 07;33(7):1362-1375
    Nakatani T et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 49
  • 文献情報:
    Pacicca DM et al. Elevated glucose acts directly on osteocytes to increase sclerostin expression in diabetes. Sci Rep 2019 11;9(1):17353
    Pacicca DM et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 50
  • 文献情報:
    Nguyen-Yamamoto L et al. Vitamin D-regulated osteocytic sclerostin and BMP2 modulate uremic extraskeletal calcification. JCI Insight 2019 07;4(13)
    Nguyen-Yamamoto L et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 51
  • 文献情報:
    Koide M et al. Sclerostin expression in trabecular bone is downregulated by osteoclasts. Sci Rep 2020 08;10(1):13751
    Koide M et al
    2020/01/01
  • 備考:
    Species: Mouse, Applications: IHC
  • 参照:
    PubMed
  • No.: 52
  • 文献情報:
    Song JY et al. <i>Hox</i> genes maintain critical roles in the adult skeleton. Proc Natl Acad Sci U S A 2020 03;117(13):7296-7304
    Song JY et al
    2020/01/01
  • 備考:
    Species: Mouse, Applications: IHC
  • 参照:
    PubMed